Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT03087747
Other study ID # AChol
Secondary ID
Status Withdrawn
Phase
First received
Last updated
Start date January 1, 2015
Est. completion date May 1, 2020

Study information

Verified date May 2021
Source University of Split, School of Medicine
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

In a setting of acute cholecystitis (AC) one of the treatment option is percutaneous transhepatic cholangiography (PTHC) drainage. The goal of current study is to evaluate some radiology aspects and correlate with clinical patient outcomes in patients with acute cholecystitis severity grade III (presented as acute cholecystitis with organ dysfunction).


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date May 1, 2020
Est. primary completion date October 1, 2019
Accepts healthy volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - clinical markers of acute cholecystitis - diagnosis confirmed with some imaging technique: computed tomography (CT), ultrasound (US). Exclusion Criteria: - clinical diagnosis was not confirmed with imaging.

Study Design


Intervention

Procedure:
Percutaneous cholecystostomy
Placement of drainage catheter into gallbladder lumen in order to evacuate inflamed content.

Locations

Country Name City State
Croatia University of Split, School of Medicine Split

Sponsors (1)

Lead Sponsor Collaborator
University of Split, School of Medicine

Country where clinical trial is conducted

Croatia, 

Outcome

Type Measure Description Time frame Safety issue
Primary C-reactive protein (CRP) C-reactive protein (CRP) is a protein found in blood plasma, whose levels rise in response to inflammation. Up to 8 weeks.
Secondary Drainage duration (expressed in days) The drain which is placed in gallbladder during Percutaneous transhepatic cholangiography (PTHC) remains there until resolving clinical parameters of acute cholecystitis. Up to 16 weeks.
Secondary White blood cells (WBCs) count White blood cells (WBCs) are the cells of the immune system. During inflammation White blood cell level rise. Up to 8 weeks.
See also
  Status Clinical Trial Phase
Completed NCT03767881 - AXIOS™ for Gallbladder Drainage as an Alternative to Percutaneous Drainage IDE N/A
Recruiting NCT05975385 - Acupuncture for Prevention of Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy N/A
Completed NCT03470220 - The Role of Ultrasound in Cholecystitis
Recruiting NCT02972944 - Laparoscopic Cholecystectomy or Conservative Treatment in the Acute Cholecystitis of Elderly Patients N/A
Recruiting NCT05702775 - Endosonography-guided Gallbladder Drainage vs Non-endoscopic Treatment in Inoperable Acute Cholecystitis N/A
Recruiting NCT04542512 - Risk Factors for Necrotic Cholecystitis During COVID-19 Pandemic.
Recruiting NCT04103762 - Interest of Intravenous Cholangiography With Indocyanine Green in the Context of Laparoscopic Cholecystectomy for Grade 1 and 2 Acute Gallstone Cholecystitis N/A
Completed NCT03014817 - Ultrasonically Activated Scalpel Versus Electrocautery Based Dissection in Acute Cholecystitis Trial N/A
Active, not recruiting NCT04612413 - A Phase 2 Study Evaluating Efficacy, Safety and Tolerability of Different Doses and Regimens of Allocetra-OTS for the Treatment of Organ Failure in Adult Sepsis Patients Phase 2
Withdrawn NCT04167072 - Observation vs Early Removal of LAMS in EUS Guided Cholecystoenterostomy N/A
Completed NCT04874103 - Hong Kong Follow up Protocol After EUS Gallbladder Drainage for Acute Cholecistitis
Completed NCT05041686 - Usefulness of the CADISS® System for the Cleavage of Severe Adhesions in Cholecystectomy N/A
Not yet recruiting NCT05339282 - Effectiveness of Empirical Antibiotic Use in Mild to Moderate Acute Inflammatory Gallbladder Disease N/A
Recruiting NCT06330688 - Prospective Evaluation of Ultrasound-guided Percutaneous Cholecystostomy With the Trocar Technique
Completed NCT02619149 - Piperacllin Versus Placebo in Patients Undergoing Surgery for Acute Cholecystitis Phase 3
Not yet recruiting NCT04661371 - Necessity of Preoperative Empirical Antibiotic Use in Acute Cholecystitis N/A
Completed NCT03050242 - Benefits of Glycopyrrolate on Intubation With Rigid-videostylet (OptiScope®) N/A
Completed NCT06178848 - EEG Parameters Between Remimazolam- and Propofol-based Anesthesia N/A
Completed NCT02394327 - Endoscopic Nasogallbladder Drainage Versus Gallbladder Stenting Before Cholecystecomy N/A
Completed NCT05179629 - M-Tapa Block for Laparoscopic Cholesistectomy N/A